Widely Used Type 2 Diabetes Drug May Reduce Cancer Death Risk
FRIDAY, April 15, 2016 (HealthDay News) -- Metformin, a commonly prescribed diabetes drug, may reduce the risk of dying from some cancers for postmenopausal women with type 2 diabetes, a new study suggests.